|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910437992603321 |
|
|
Titolo |
Advances in DNA repair in cancer therapy / / Lawrence Panasci, Raquel Aloyz, Moulay Alaoui-Jamali, editors |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
New York, : Springer, 2013 |
|
|
|
|
|
|
|
ISBN |
|
1-283-93366-7 |
1-4614-4741-0 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed. 2013.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (316 p.) |
|
|
|
|
|
|
Collana |
|
Cancer drug discovery and development |
|
|
|
|
|
|
Altri autori (Persone) |
|
PanasciLawrence |
AloyzRaquel |
Alaoui-JamaliMoulay |
|
|
|
|
|
|
|
|
Disciplina |
|
616.99 |
616.99/4061 |
616.99406 |
|
|
|
|
|
|
|
|
Soggetti |
|
Cancer - Treatment - Genetic aspects |
DNA repair |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Preface -- Repair of DNA Interstrand Cross-links Produced by Cancer Chemotherapeutic Drugs -- DNA-PK, a pharmacological target in cancer chemotherapy and radiotherapy? -- Growth factor receptor signaling, DNA damage response, and cancer cell susceptibility to chemotherapy and relapses -- The relationship between DNA-repair genes, cellular radiosensitivity and the response of tumors and normal tissues to radiotherapy -- Important Roles of ERCC1 in DNA Repair and Targeted Therapy -- The role of BRCA1 and BRCA2 in anticancer drug therapy -- DNA-PK in CLL Chemotherapy -- Poly(ADP) ribose polymerase at the interface of DNA damage signalling and DNA repair -- Cellular protection against the antitumor drug bleomycin -- ATR as a Therapeutic Target -- Telomeres, Telomerase and DNA Damage Response in Cancer Therapy -- RAD51 is a key protein of DNA repair and homologous recombination in humans -- Index. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
This book deals with the emerging role of various DNA repair proteins and the regulatory elements which are implicated in cancer therapy such as DNA cross-linking agents, radiotherapy and bleomycin. The |
|
|
|
|